Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 4/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250955 | 0.83 | TDP1 (0.68) | CASP1FFAR1TDP1PKMSMN1; SMN2 | |
| SCHEMBL14732624 | 0.83 | SMN1; SMN2 (0.45) | CASP1FFAR1TDP1SMN1; SMN2MGLL | |
| SCHEMBL14306494 | 0.82 | FFAR1 (0.52) | FFAR1TDP1MGLLMMP12TRPV1 | |
| SCHEMBL14732636 | 0.82 | SMN1; SMN2 (0.44) | CASP1FFAR1TDP1SMN1; SMN2MGLL | |
| SCHEMBL13410149 | 0.82 | TDP1 (0.58) | FFAR1TDP1MGLLMMP12CYP4F2 | |
| SCHEMBL10093000 | 0.81 | FFAR1 (0.44) | CASP1FFAR1TDP1MGLLMMP12 | |
| SCHEMBL7756846 | 0.81 | CYP4F2 (0.59) | FFAR1TDP1SMN1; SMN2MGLLMMP12 | |
| SCHEMBL2602542 | 0.81 | TDP1 (0.43) | FFAR1TDP1SMN1; SMN2MGLLMMP12 | |
| SCHEMBL2602526 | 0.81 | TDP1 (0.43) | FFAR1TDP1SMN1; SMN2MGLLMMP12 | |
| SCHEMBL13943204 | 0.80 | FFAR1 (0.54) | FFAR1TDP1MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8748070-B2 | Thiol group-containing charge transporting material, thiol group-containing charge transporting material-dissolving solution, photoelectric conversion device, electrophotographic photoreceptor, image forming apparatus, and process cartridge | FUJI XEROX CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| US-8748070-B2 | Thiol group-containing charge transporting material, thiol group-containing charge transporting material-dissolving solution, photoelectric conversion device, electrophotographic photoreceptor, image forming apparatus, and process cartridge | FUJI XEROX CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| US-20120196215-A1 | THIOL GROUP-CONTAINING CHARGE TRANSPORTING MATERIAL, THIOL GROUP-CONTAINING CHARGE TRANSPORTING MATERIAL-DISSOLVING SOLUTION, PHOTOELECTRIC CONVERSION DEVICE, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, IMAGE FORMING APPARATUS, AND PROCESS CARTRIDGE | FUJI XEROX CO., LTD. (JP) | 2012-08-02 | — | — | US | disclosed |
| US-20120196215-A1 | THIOL GROUP-CONTAINING CHARGE TRANSPORTING MATERIAL, THIOL GROUP-CONTAINING CHARGE TRANSPORTING MATERIAL-DISSOLVING SOLUTION, PHOTOELECTRIC CONVERSION DEVICE, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, IMAGE FORMING APPARATUS, AND PROCESS CARTRIDGE | FUJI XEROX CO., LTD. (JP) | 2012-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120196215-A1 | THIOL GROUP-CONTAINING CHARGE TRANSPORTING MATERIAL, THIOL GROUP-CONTAINING CHARGE TRANSPORTING MATERIAL-DISSOLVING SOLUTION, PHOTOELECTRIC CONVERSION DEVICE, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, IMAGE FORMING APPARATUS, AND PROCESS CARTRIDGE | SLC9A1, SLC26A3, SLC26A4 | CASP1 1567/4885FFAR1 3229/4885TDP1 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.